#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gastric cancer Hyperinsulinism Desmoid tumour Antisynthetase syndrome Juvenile psoriatic arthritis Nasopharyngeal cancer Kaposi's sarcoma Sarcoidosis Cholangiosarcoma PIK3CA related overgrowth spectrum Chronic kidney disease Anti-myelin-associated glycoprotein associated polyneuropathy ROHHAD syndrome Pustular psoriasis Brain stem glioma More trials…

    Learn about Rare Diseases

    Biotinidase deficiency – Basic Information Progressive multifocal leukoencephalopathy – Life with Disease Angiosarcoma metastatic – Life with Disease Turner’s syndrome – Life with Disease Primary biliary cholangitis – Treatment Acute respiratory distress syndrome – Trials in Disease Usher’s syndrome – Trials in Disease Mantle cell lymphoma – Basic Information Synovial sarcoma metastatic – Trials in Disease Hepatic angiosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amitriptyline Hydrochloride Dinutuximab Beta Astegolimab Padeliporfin Benztropine Mesylate Sodium Phosphate Dodecahydrate Bay 3283142 Pantoprazole Histamine Dihydrochloride Leniolisib Phosphate Fluoxetine Hydrochloride Gallium (68Ga) Neflamapimod Clascoterone GSK4418959A Tetracaine Hydrochloride 18F-Psma-1007 Sodium Hyaluronate Follitropin Delta Valproic Acid More therapies…

    Learn about Your Condition

    Epiphysiolysis Hip arthroplasty Carpal tunnel syndrome Colitis Cerebral palsy Torticollis Mantle cell lymphoma stage IV Rheumatic disorder Radiation skin injury Infectious pleural effusion Post procedural complication Asthma Psychotic disorder Optic ischaemic neuropathy Endometrial stromal sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of Faricimab Treatment Given Every 24 Weeks in Patients with Age-Related Macular Degeneration

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Faricimab
    France Germany Italy Spain

  • Study on Golcadomide for Patients with Relapsed or Refractory Large B-Cell Lymphoma in the Brain

    Recruiting

    2 1 1
    Investigated Drugs:
    • Golcadomide
    Belgium The Netherlands

  • Study of ibuzatrelvir tablets in non-hospitalized adults and adolescents with COVID-19 who are at high risk of developing severe illness

    Recruiting

    3 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • IBUZATRELVIR
    Belgium Bulgaria Czechia Denmark Finland Germany +2

  • Study on the Effects of Low Dose Choriogonadotropin Alfa in Women with Diminished Ovarian Reserve Undergoing IVF/ICSI

    Recruiting

    3 1 1
    Investigated Diseases:
    • Diminished ovarian reserve
    Investigated Drugs:
    • Choriogonadotropin Alfa
    Denmark

  • Study on Azacitidine, Roginolisib, and Golcadomide for Patients with Relapsed or Refractory Peripheral T-Cell Lymphomas

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Peripheral T-cell lymphoma unspecified
    Investigated Drugs:
    • Roginolisib
    • Azacitidine
    • Golcadomide
    France

  • Study on the Safety and Effectiveness of Patritumab Deruxtecan for Children with Relapsed or Refractory Hepatoblastoma and Rhabdomyosarcoma

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • 1,3-BUTYLENE GLYCOL
    • Cinchocaine Hydrochloride
    • Patritumab Deruxtecan
    Belgium Czechia Denmark France Germany Greece +6
Previous Page
1 … 203 204 205 206 207 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!